Author: Ravi Shankar

TORONTO and PERTH, Western Australia, Sept. 18, 2026 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (Cygnus or the Company) refers to the proposed transaction under which Central Asia Metals PLC (AIM: CAML) (CAML) will acquire 100% of the shares in Cygnus pursuant to a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) (Corporations Act), (Scheme).

Cygnus is pleased to announce that Scheme Shareholders today voted in favour of the Scheme.

Capitalised terms in this announcement that are not otherwise defined have the meaning given to them in the Scheme Booklet dated 13 August 2026.

Results of the Scheme Meeting

In accordance with ASX Listing Rule 3.13.2 and section 251AA(2) of the Corporations Act, Cygnus advises that the Scheme Resolution was passed by the Minority Approval Vote and the Requisite Majorities of Cygnus Shareholders at the Scheme Meeting held earlier today.

In summary, at the Scheme Meeting voting on the Scheme Resolution was conducted and carried out on a poll, and was passed by the following majorities:

• 81.38% of Cygnus Shareholders present and voting at the Scheme Meeting (in-person, or by proxy, corporate representative or attorney) were in favour of the Scheme Resolution;
• 98.35% of the total number of votes cast by Cygnus Shareholders at the Scheme Meeting were in favour of the Scheme Resolution; and
• 97.88% of the total numbers of votes cast by Scheme Shareholders at the Scheme Meeting (in-person or by proxy, corporate representative or attorney), voting as a single class, on the basis of one vote per Scheme Share held, excluding for the purposes of the Minority Approval Vote, those votes required to be excluded by MI 61-101.

Details of the valid proxies received and votes cast at the Scheme Meeting are set out in Annexure A and Annexure B to this announcement.

Next steps

Cygnus will apply to the Supreme Court of Western Australia (Court) for approval of the Scheme at a hearing scheduled at 2:15pm (AWST) on Wednesday, 23 September 2026 (Second Court Hearing).¹

If the Court approves the Scheme at the Second Court Hearing, Cygnus intends to lodge a copy of the Court orders with ASIC on the following day (Thursday, 24 September 2026), when the Scheme will become Effective. It is expected that Cygnus will be suspended from trading on the ASX from the close of trading on Thursday, 24 September 2026 and the TSXV from the close of trading on Wednesday, 23 September 2026, and the Scheme will be implemented on Monday, 5 October 2026.

Indicative timetable

The key dates and times for implementation of the Scheme are as follows:

Event	Date and time (2026)*
Second Court Date	2:15pm (AWST), Wednesday, 23 September
Lodgement of Court orders with ASIC Effective Date	Thursday, 24 September
Election forms deadline	5.00pm (AWST) / 5.00am (EDT), Thursday, 24 September
Record Date	5.00pm (AWST), Monday, 28 September
Implementation Date	Monday, 5 October
New CAML Shares to commence trading on AIM	Monday, 5 October

*All stated dates and times are indicative only. The actual timetable will depend on many factors outside the control of Cygnus and CAML, including the Court approval process and the satisfaction or waiver (where applicable) of the conditions precedent to completion of the Scheme. Any changes to the above timetable will be announced to ASX and will be available under Cygnus’ profile on ASX at https://www.asx.com.au/.

Further information

If you have any questions about the Scheme, please contact Cygnus’ Scheme Information Line on 1300 103 401 (from within Australia) or +61 2 9066 4063 (from outside Australia), Monday to Friday (excluding Australian public holidays) between 8:30am to 5:00pm (AWST).

This announcement has been authorised for release by the Board of Cygnus Metals Limited.

David Southam	Nicholas Kwong	Media:
Executive Chair	President & CEO	Paul Armstrong
T: +61 8 6118 1627	T: +1 418 748 5076	Read Corporate
E: info@cygnusmetals.com	E: info@cygnusmetals.com	T: +61 8 9388 1474

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this announcement may constitute “forward-looking information” within the meaning of applicable securities laws. Examples of forward-looking statements in this announcement include, among others, statements regarding: the completion of the Scheme and the remaining related steps therefor, including timing thereof. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or timing to differ materially from those anticipated or implied by such forward-looking information. Information about the risks and assumptions affecting the forward-looking information herein can be found in the “Risk Factors” section in the Scheme Booklet dated 13 August 2026, a copy of which is available under Cygnus’ profile on SEDAR+ at www.sedarplus.ca. All of the forward-looking information in this announcement is qualified by these cautionary statements. Cygnus assumes no obligation to publicly update or revise such information, except as may be required by applicable law and the rules of the ASX and the TSX Venture Exchange.  

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Annexure A: Scheme Resolution voting and proxy results

http://ml.globenewswire.com/Resource/Download/fa6230bd-e10a-4e80-9c59-61fb4a0ced4c

Annexure B: Minority Approval voting and proxy results

http://ml.globenewswire.com/Resource/Download/dd9d6e7e-2c09-4294-8f0d-f9183f367e91

____________________________________________

1. The Second Court Hearing may not take place at this time and date if all of the conditions precedent to the Scheme (other than approval of the Scheme at the Second Court Hearing) have not been satisfied or waived (as applicable) before the Delivery Time on the Second Court Date. Details of the conditions precedent to the Scheme are included in section 8.1(c) of the Scheme Booklet. For a full copy of the Scheme Booklet, refer to Cygnus’ ASX announcement dated 13 August 2026 titled “Scheme Booklet registered by ASIC”. Cygnus Shareholders should refer to Cygnus’ ASX announcement dated 14 September 2026 titled “Update on Scheme of Arrangement” which provides an update on the status of the conditions precedent to the Scheme, including the Kazakhstan regulatory approval condition precedent which has not yet been satisfied. Any changes to the Second Court Date or the Scheme timetable set out in the Scheme Booklet will be announced to ASX and available under Cygnus’ profile at www.asx.com.au.

FORT LAUDERDALE, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (Nasdaq: TCRT) today announced that it has entered into definitive agreements with institutional investors in a registered direct offering for the sale of 380,469 shares of its common stock and pre-funded warrants to purchase up to 386,654 shares of common stock at a price of $1.46 per share, for aggregate gross proceeds of approximately $1,120,000, before deducting placement agent fees and offering expenses. The offering was priced at-the-market under Nasdaq rules. The offering is expected to close on or about September 21, 2026, subject to the satisfaction of customary closing conditions.

The Company intends to use the net proceeds from the offering primarily for general working capital and corporate purposes.

Dawson James Securities, Inc. is acting as sole placement agent for the offering.

The securities will be offered and sold pursuant to an effective shelf registration statement on Form S-3 (File No. 333-289748), including a base prospectus, initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 11, 2025 and became effective on December 1, 2025. The offering will be made only by means of a written prospectus. A prospectus supplement and accompanying prospectus describing the terms of the offering will be filed with the SEC on its website at www.sec.gov. Copies of the prospectus supplement and the accompanying prospectus relating to the offering may also be obtained, when available, from the offices of Dawson James Securities, Inc. 2700 N Military Trail, Suite 100, Boca Raton, FL, 33431 or by email at investmentbanking@dawsonjames.com.

Interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Alaunos Therapeutics

Alaunos Therapeutics is a biotechnology company focused on developing novel therapeutics. The Company’s obesity and metabolic disorders program is advancing ALN1003, an oral small-molecule candidate being evaluated as a potential differentiated, non-hormonal, non-incretin approach for obesity- and metabolic-disease-relevant biology.

Forward-Looking Statements

This press release may include “forward-looking statements” pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. To the extent that the information presented in this press release discusses financial projections, information, or expectations about our business plans, results of operations, products, or markets, or otherwise makes statements about future events, such statements are forward-looking. Such forward-looking statements can be identified by the use of words such as “should”, “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” and “proposes.” Although we believe that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” and elsewhere in documents that we file from time to time with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained, and Alaunos Therapeutics, Inc., does not undertake any duty to update any forward-looking statements except as may be required by law.

Investor / Media Contact

ir@alaunos.com

TORONTO, Sept. 18, 2026 (GLOBE NEWSWIRE) — Income Financial Trust (“Income Financial”) declares its monthly distribution of $0.08642 per unit. The distribution is payable October 9, 2026 to unit holders on record as at September 30, 2026. 

Under the distribution policy announced on November 18, 2013, the monthly distribution is determined by applying a 10.00% annualized rate on the volume weighted average market price (VWAP) of Income Financial’s units over the last 3 trading days of the preceding month. As a result, holders of record on September 30, 2026 will receive a dividend of $0.08642 per unit based on the VWAP of $10.37 payable on October 9, 2026. The yield will remain stable at 10.00% (based on the VWAP) under this distribution policy.

Income Financial unitholders have received a total of $40.41 per unit in distributions since inception, inclusive of this distribution.

Income Financial invests in a portfolio of North American financial services companies including some of the strongest Canadian & U.S. banks, life insurance and investment firms.

Distribution Details
Trust Unit (INC.UN)			$0.08642
Record Date:			September 30, 2026
Payable Date:			October 9, 2026
Investor Relations: 1-877-478-2372	Local: 416-304-4443	www.quadravest.com	info@quadravest.com

TORONTO, Sept. 18, 2026 (GLOBE NEWSWIRE) — Financial 15 Split Corp. (“Financial 15”) declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annualized) and $0.06042 for each Preferred share ($0.725 annually). Distributions are payable October 9, 2026 to shareholders on record as at September 30, 2026. 

Since inception Class A shareholders have received a total of $29.20 per share and Preferred shareholders have received a total of $13.50 per share inclusive of this distribution, for a combined total of $42.71.

Financial 15 invests in a high quality portfolio consisting primarily of financial services companies made up of Canadian and U.S. issuers as follows: Bank of Montreal, The Bank of Nova Scotia, Canadian Imperial Bank of Commerce, Royal Bank of Canada, Toronto-Dominion Bank, National Bank of Canada, Manulife Financial Corporation, Sun Life Financial, Great-West Lifeco, Bank of America, Citigroup Inc., Goldman Sachs Group, JP Morgan Chase & Co. and Wells Fargo & Co.

Distribution Details
Class A Share (FTN)	$0.12570
Preferred Share (FTN.PR.A)	$0.06042
Record Date:	September 30, 2026
Payable Date:	October 9, 2026

Investor Relations: 1-877-478-2372
Local: 416-304-4443
www.financial15.com
info@quadravest.com 

TORONTO, Sept. 18, 2026 (GLOBE NEWSWIRE) — Canadian Life Companies Split Corp. (the “Company”) declares its monthly distribution of $0.10000 for each Class A share ($1.20 annualized) and $0.05833 for each Preferred share ($0.700 annualized). Distributions are payable October 9, 2026 to shareholders on record as at September 30, 2026.

Since inception Class A shareholders have received a total of $10.65 per share and Preferred shareholders have received a total of $13.32 per share inclusive of this distribution, for a combined total of $23.97 per unit.

The Company invests primarily in a portfolio of four publicly traded Canadian life insurance companies as follows: Great-West Lifeco Inc., Industrial Alliance Insurance & Financial Services Inc., Manulife Financial Corporation and Sun Life Financial Inc.

Distribution Details
Class A Share (LFE)	$0.10000
Preferred Share (LFE.PR.B	$0.05833
Record Date:	September 30, 2026
Payable Date:	October 9, 2026

Investor Relations: 1-877-478-2372
Local: 416-304-4443
www.lifesplit.com
info@quadravest.com

TORONTO, Sept. 18, 2026 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. (The “Company”) declares its monthly distribution of $0.10000 for each Class A share ($1.20 annualized) and $0.05833 for each Preferred share ($0.700 annually). Distributions are payable October 9, 2026 to shareholders on record as at September 30, 2026.

Since inception Class A shareholders have received a total of $29.60 per share and Preferred shareholders have received a total of $12.28 per share inclusive of this distribution, for a combined total of $41.88.

Dividend 15 invests primarily in a high quality portfolio of leading Canadian dividend-yielding stocks as follows: Bank of Montreal, Bank of Nova Scotia, Canadian Imperial Bank of Commerce, Royal Bank of Canada, Toronto-Dominion Bank, National Bank of Canada, BCE Inc., Manulife Financial, Enbridge, Sun Life Financial, TELUS Corporation, Thomson Reuters Corporation, TransAlta Corporation, TC Energy Corporation.

Distribution Details
Class A Share (DFN)	$0.10000
Preferred Share (DFN.PR.A)	$0.05833
Record Date:	September 30, 2026
Payable Date:	October 9, 2026

Investor Relations: 1-877-478-2372

Local: 416-304-4443

www.dividend15.com

info@quadravest.com

TORONTO, Sept. 18, 2026 (GLOBE NEWSWIRE) — North American Financial 15 Split Corp. (The “Company”) declares its regular monthly distribution of $0.11335 for each Class A share ($1.3602 annualized) and $0.06250 for each Preferred share ($0.750 annually). Distributions are payable October 9, 2026 to shareholders on record as at September 30, 2026.

Since inception Class A shareholders have received a total of $19.67 per share and Preferred shareholders have received a total of $13.12 per share inclusive of this distribution, for a combined total of $32.79.

The Company invests in a high quality portfolio primarily consisting of financial services companies made up of Canadian and U.S. issuers as follows: Bank of Montreal, The Bank of Nova Scotia, Canadian Imperial Bank of Commerce, Royal Bank of Canada, Toronto-Dominion Bank, National Bank of Canada, Manulife Financial Corporation, Sun Life Financial, Great-West Lifeco, Bank of America, Citigroup Inc., Goldman Sachs Group, JP Morgan Chase & Co. and Wells Fargo & Co.

Distribution Details
Class A Share (FFN)			$0.11335
Preferred Share (FFN.PR.A)			$0.06250
Record Date:			September 30, 2026
Payable Date:			October 9, 2026
Investor Relations: 1-877-478-2372	Local: 416-304-4443	www.financial15.com	info@quadravest.com

TORONTO, Sept. 18, 2026 (GLOBE NEWSWIRE) — Canadian Banc Corp. (The “Company”) declares its monthly distribution of $0.20675 for each Class A share and $0.04958 for each Preferred share. Distributions are payable October 9, 2026 to shareholders on record as at September 30, 2026.

Under the distribution policy announced in November 2021, the monthly dividend payable on the Class A shares is determined by applying a 15% annualized rate on the volume weighted average market price (VWAP) of the Class A shares over the last 3 trading days of the preceding month. As a result, Class A shareholders of record on September 30, 2026 will receive a dividend of $0.20675 per share based on the VWAP of $16.54 payable on October 9, 2026. The yield will remain stable at 15.00% (based on the VWAP) under this distribution policy.

Preferred shareholders will receive prime plus 1.50% with a minimum rate of 5.00% and a maximum rate of 8.00%.

Since inception Class A shareholders have received a total of $26.64 per share and Preferred shareholders have received a total of $11.98 per share inclusive of this distribution, for a combined total of $38.62.

The Company invests primarily in a portfolio of six publicly traded Canadian Banks as follows: Bank of Montreal, Canadian Imperial Bank of Commerce, National Bank of Canada, Royal Bank of Canada, Bank of Nova Scotia, Toronto-Dominion Bank. Shares held within the portfolio are expected to range between 5- 20% in weight but may vary at any time. To generate additional returns above the dividend income earned PRESS RELEASE on the portfolio, The Company engages in a selective covered call writing program.

Distribution Details
Class A Share (BK)	$0.20675
Preferred Share (BK.PR.A)	$0.04958
Record Date:	September 30, 2026
Payable Date:	October 9, 2026

Investor Relations: 1-877-478-2372

Local: 416-304-4443

http://www.canadianbanc.com/

info@quadravest.com

TORONTO, Sept. 18, 2026 (GLOBE NEWSWIRE) — US Financial 15 Split Corp (“US Financial 15”) declares its monthly distribution of $0.07883 for each Preferred share, or 10.00% annually based on the previous month end net asset value. Distributions are payable October 9, 2026 to shareholders on record as at September 30, 2026.

US Financial 15 invests in a portfolio primarily consisting of 15 U.S. financial services companies as follows: American Express, Bank of America, Bank of New York Mellon Corp., Citigroup, CME Group Inc., Fifth Third Bancorp, The Goldman Sachs Group, J.P. Morgan Chase & Co., Morgan Stanley, PNC Financial Services Group Inc., Regions Financial Corp., State Street Corp., SunTrust Banks, U.S. Bancorp, and Wells Fargo.

Distribution Details
Preferred Share (FTU.PR.B)	$0.07883
Record Date:	September 30, 2026
Payable Date:	October 9, 2026

Investor Relations: 1-877-478-2372
Local: 416-304-4443
www.financial15.com
info@quadravest.com

TORONTO, Sept. 18, 2026 (GLOBE NEWSWIRE) — Prime Dividend Corp. (The “Company”) declares its monthly distribution of $0.13267 for each Class A share and $0.05667 for each Preferred share. Distributions are payable October 9, 2026 to shareholders on record as at September 30, 2026.

Under the distribution policy announced on July 17, 2014, the monthly dividend payable on the Class A shares is determined by applying a 10.00% annualized rate on the volume weighted average market price (VWAP) of the Class A shares over the last 5 trading days of the preceding month. As a result, Class A shareholders of record on September 30, 2026 will receive a dividend of $0.13267 per share based on the VWAP of $15.92 payable on October 9, 2026. The yield will remain stable at 10.00% (based on the VWAP) under this distribution policy.

Preferred shareholders will receive prime plus 2.35% with a minimum rate of 5.00% and a maximum rate.

Since inception Class A shareholders have received a total of $15.86 per share and Preferred shareholders have received a total of $12.13 per share inclusive of this distribution, for a combined total of $27.99.

The Company invests primarily in a portfolio of high yielding Canadian Companies as follows:

Banks	Investment Management	Life Insurance	Utilities & Other
Bank of Montreal	AGF Management Ltd.	Great-West Lifeco Inc.	BCE Inc.
Bank of Nova Scotia	IGM Financial Inc.	Manulife Financial Corporation	TransAlta Corp.
CIBC		Sun Life Financial Inc.	TC Energy Corp.
National Bank of Canada			Power Financial Corp.
Royal Bank of Canada			TMX Group Inc.
Toronto-Dominion Bank

Distribution Details

Class A Share (PDV)	$0.13267
Preferred Share (PDV.PR.A)	$0.05667
Record Date:	September 30, 2026
Payable Date:	October 9, 2026

Investor Relations: 1-877-478-2372

Local: 416-304-4443

www.primedividend.com

info@quadravest.com